Our Mission

At CogniScreen, we are transforming dementia assessment with cutting-edge technology, enhancing early detection and nuanced understanding of various dementia types. By leveraging AI and standard healthcare data, our innovative solution excels in identifying and differentiating mixed dementias with unparalleled accuracy.

We are focused on accelerating Alzheimer's research by vastly improving the screening process for pharmaceutical clinical trials.

Our Research

CogniScreen is based on a foundation of research, that has been developed at the Kolachalama Lab in Boston University, which has been published in leading industry journals.